正子断层扫描 (PET) 市场机会、成长动力、产业趋势分析和 2025 - 2034 年预测

2024 年全球正子断层扫描市场价值 21 亿美元，预计将大幅成长，预计 2025 年至 2034 年的复合年增长率为 6.1%。 PET 技术是一种尖端成像方法，透过提供高解析度功能影像来揭示体内的代谢和生理活动，已成为医学诊断中不可或缺的一部分。其精确的影像能力对于诊断、监测和管理复杂的医疗状况至关重要。癌症、心血管疾病和神经系统疾病等慢性疾病的发生率不断上升，进一步推动了对 PET 扫描仪等先进诊断工具的需求。随着世界各地的医疗保健系统强调早期检测和精准医疗，PET 影像正在广泛的应用，巩固了其在现代临床实践中的作用。

快速的技术进步正在拓展 PET 的应用范围并改变其在疾病管理中的作用。一项值得注意的创新是飞行时间 PET 技术，它透过计算光子在源和探测器之间传播的时间来提高影像解析度并减少扫描时间。这项突破不仅实现了更快的成像，而且还提供了更高品质的视觉效果，使其成为 PET 市场未来成长的基石。医疗保健提供者越来越认识到此类技术在改善患者治疗效果方面的价值，这推动了对 PET 创新的进一步投资。

按产品类型，市场分为部分环 PET 扫描仪和全环 PET 扫描仪，后者将在 2024 年引领市场，创造 17 亿美元的收入。全环 PET 扫描仪因其多功能性而备受讚誉，因为它们支持肿瘤学、心臟病学、神经病学和精神病学等广泛的应用。他们能够为不同的临床专业提供详细的影像，从而确保他们在市场上持续占据主导地位。人们对 PET 诊断准确性的认识不断提高，加上对个人化医疗的需求不断增长以及影像技术的进步，进一步推动了全环 PET 系统的采用。

根据侦测器类型，市场包括数位光子计数器 (DPC)、硅光电倍增管 (SiPM)、镥钇正硅酸盐 (LYSO)、镥氧正硅酸盐 (LSO) 和其他侦测器技术。 LSO 探测器在 2024 年脱颖而出，为市场贡献了 7.251 亿美元。这些探测器因其卓越的灵敏度、增强的空间解析度和更快的成像能力而备受追捧。 LSO 晶体的先进性能，包括其快速的光衰减时间和精确的光子检测，使其在 PET 领域脱颖而出，成为尖端成像系统的首选。

美国 PET 市场将于 2024 年创造 7.138 亿美元的产值，并预计在整个预测期内持续成长。慢性病（尤其是癌症和心血管疾病）发生率的上升推动了先进影像解决方案的采用。加上 PET 技术的不断进步，例如解析度的提高和扫描时间的缩短，美国市场仍然处于全球 PET 创新的前沿。

目录

第 1 章：方法论与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 将 X 光电脑断层扫描 (CT) 整合到 PET 中
    • 正子断层扫描技术进步
    • 放射性药物 PET 分析需求不断成长
    • 越来越多地转向影像引导干预
  • 产业陷阱与挑战
    • 放射性同位素的寿命缩短
    • 严格的监管环境
• 成长潜力分析
• 监管格局
  • 我们
  • 欧洲
• 技术格局
• 未来市场趋势
• 重要新闻和倡议
• 差距分析
• 波特的分析
• PESTEL 分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第 5 章：市场估计与预测：按产品类型，2021 年至 2034 年

• 主要趋势
• 部分环形 PET 扫描仪
• 全环 PET 扫描仪

第六章：市场估计与预测：按探测器类型，2021 – 2034 年

• 主要趋势
• 氧化硅酸镥 (LSO)
• 硅光电倍增管 (SiPM)
• 硅酸钇镥 (LYSO)
• 数位光子计数器（DPC）
• 其他探测器类型

第 7 章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 医院
• 诊断中心
• 门诊手术中心
• 其他最终用途

第 8 章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第九章：公司简介

• Canon Medical Systems Corporation
• CMR Naviscan
• Fujifilm Holdings Corporation
• GE Healthcare
• Koninklijke Philips
• Mediso
• Minfound Medical Systems
• Molecubes
• Neusoft Corporation
• Oncovision
• Positron
• Radialis
• Siemens Healthineers
• Toshiba International Corporation
• Yangzhou Kindsway Biotech

The Global Positron Emission Tomography Market, valued at USD 2.1 billion in 2024, is poised for significant growth, with a projected CAGR of 6.1% from 2025 to 2034. PET technology, a cutting-edge imaging method, has become indispensable in medical diagnostics by providing high-resolution functional images that reveal metabolic and physiological activities within the body. Its precise imaging capabilities are vital in diagnosing, monitoring, and managing complex medical conditions. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions is further driving demand for advanced diagnostic tools like PET scanners. As healthcare systems worldwide emphasize early detection and precision medicine, PET imaging is gaining widespread adoption, cementing its role in modern clinical practices.

Rapid technological advancements are broadening PET's applications and transforming its role in disease management. One notable innovation is time-of-flight PET technology, which enhances image resolution and reduces scan times by calculating the time photons take to travel between the source and detector. This breakthrough not only enables faster imaging but also delivers superior-quality visuals, making it a cornerstone of the PET market's future growth. Healthcare providers are increasingly recognizing the value of such technologies in improving patient outcomes, which is fueling further investment in PET innovations.

The market is segmented by product type into partial ring PET scanners and full ring PET scanners, with the latter leading the market in 2024 by generating USD 1.7 billion in revenue. Full-ring PET scanners are celebrated for their versatility, as they support a wide range of applications across oncology, cardiology, neurology, and psychiatry. Their ability to deliver detailed imaging across diverse clianical specialties ensures their continued dominance in the market. Growing awareness of PET's diagnostic accuracy, coupled with the rising demand for personalized medicine and advancements in imaging technology, further boosts the adoption of full ring PET systems.

By detector type, the market includes digital photon counters (DPC), silicon photomultiplier (SiPM), lutetium yttrium orthosilicate (LYSO), lutetium oxyorthosilicate (LSO), and other detector technologies. LSO detectors stood out in 2024, contributing USD 725.1 million to the market. These detectors are highly sought after for their superior sensitivity, enhanced spatial resolution, and faster imaging capabilities. The advanced performance of LSO crystals, including their rapid light decay time and precise photon detection, sets them apart in the PET landscape, making them a preferred choice for cutting-edge imaging systems.

The U.S. PET market, generating USD 713.8 million in 2024, is positioned for sustained growth throughout the forecast period. The rising incidence of chronic diseases, particularly cancer and cardiovascular conditions, is driving increased adoption of advanced imaging solutions. Coupled with continuous advancements in PET technology, such as improved resolution and reduced scan durations, the U.S. market remains at the forefront of global PET innovation.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Integration of X-ray computed tomography (CT) into PET
    • 3.2.1.2 Technological advancements in positron emission tomography
    • 3.2.1.3 Rising demand for PET analysis in radio pharmaceuticals
    • 3.2.1.4 Increasing shift towards image-guided interventions
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Diminished life span of radioisotopes
    • 3.2.2.2 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Key news and initiatives
• 3.8 Gap analysis
• 3.9 Porter’s analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn, Units)

• 5.1 Key trends
• 5.2 Partial ring PET scanner
• 5.3 Full ring PET scanner

Chapter 6 Market Estimates and Forecast, By Detector Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Lutetium oxyorthosilicate (LSO)
• 6.3 Silicon photomultiplier (SiPM)
• 6.4 Lutetium yttrium orthosilicate (LYSO)
• 6.5 Digital photon counters (DPC)
• 6.6 Other detector types

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Diagnostic centers
• 7.4 Ambulatory surgical centers
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn, Units)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Canon Medical Systems Corporation
• 9.2 CMR Naviscan
• 9.3 Fujifilm Holdings Corporation
• 9.4 GE Healthcare
• 9.5 Koninklijke Philips
• 9.6 Mediso
• 9.7 Minfound Medical Systems
• 9.8 Molecubes
• 9.9 Neusoft Corporation
• 9.10 Oncovision
• 9.11 Positron
• 9.12 Radialis
• 9.13 Siemens Healthineers
• 9.14 Toshiba International Corporation
• 9.15 Yangzhou Kindsway Biotech